Hisashi Arikawa

This inventor holds 10 USPTO granted patents and 7 published patent applications and 3 EPO patents. Top assignee: Kaneka Corporation. Active years: 2018-2025.

USPTO Granted Patents = 10 (Patent Applications = 7)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 14)

Average Co-Inventor Count = 2.8

ph-index = 2

Forward Citations = 45(Granted Patents)

Location History:

Hyogo, JP (2018)
Takasago, JP (2019 - 2022)

Company Filing History:

10 out of 1,768

Kaneka Corporation

patents

Years Active: 2018-2025

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12385018 - Transformed microorganism and method of producing polyhydroxyalkanoate (2025-08-12),

2. 12351854 - Transformed microorganism and method of producing polyhydroxyalkanoate using the microorganism (2025-07-08),

3. 12286662 - Method of producing polyhydroxyalkanoate (2025-04-29),

4. 11453896 - Transformed microorganism for producing PHA copolymer comprising 3HH monomer unit at high composition rate and method for producing PHA using same (2022-09-27),

5. 11225676 - Microorganism having multiple genes encoding PHA synthase and method for producing PHA using same (2022-01-18),

6. 10876140 - Method for producing polyhydroxyalkanoic acid, and microbes (2020-12-29),

7. 10829793 - Transformant that produces copolymerized PHA containing 3HH unit, and method for producing said PHA (2020-11-10),

8. 10519473 - Microorganism having multiple genes encoding PHA synthase and method for producing PHA using same (2019-12-31),

9. 10233468 - High molecular weight PHA-producing microbe and method of producing high molecular weight PHA using same (2019-03-19),

10. 10072255 - Microorganism having regulated expression of (R)-specific enoyl-coa hydratase gene and method for producing polyhydroxyalkanoate copolymer using same (2018-09-11),

Title: Hisashi Arikawa: Innovator in Microbial Biotechnology

Introduction

Hisashi Arikawa is a prominent inventor based in Takasago, Japan. He has made significant contributions to the field of microbial biotechnology, particularly in the production of polyhydroxyalkanoates (PHAs). With a total of 10 patents to his name, Arikawa's work has the potential to impact various industries, including bioplastics and sustainable materials.

Latest Patents

Arikawa's latest patents focus on transformed microorganisms and methods for producing polyhydroxyalkanoate. One of his notable inventions involves a transformed microorganism that possesses a polyhydroxyalkanoate synthase gene, with enhanced expression of the minD gene. This innovation also includes a method for producing PHAs by culturing these microorganisms in the presence of a carbon source. Another patent details a transformed microorganism with reduced expression of the A1386 and/or A2405 genes, while enhancing the expression of minC and minD genes. This method also emphasizes the cultivation of the transformed microorganism to produce PHAs effectively.

Career Highlights

Hisashi Arikawa is currently associated with Kaneka Corporation, where he continues to advance his research and development efforts. His work has garnered attention for its innovative approach to utilizing microorganisms for sustainable production processes.

Collaborations

Arikawa collaborates with notable colleagues, including Shunsuke Sato and Keiji Matsumoto, who contribute to his research endeavors and help drive forward the innovations in microbial biotechnology.

Conclusion

Hisashi Arikawa's contributions to the field of microbial biotechnology exemplify the importance of innovation in creating sustainable solutions. His patents and ongoing research at Kaneka Corporation highlight his commitment to advancing the production of environmentally friendly materials.